Six-forty on a weekday morning, kitchen table. You wet the electrode sponges, fit the headset so one sits over the left front of your head and one over the right, and lean a tablet against the coffee maker. You tap start, and for the next half hour you play a video game while a weak electrical current runs through your prefrontal cortex. Or doesn’t. You have no way of knowing which. That was the routine for about a hundred adults with major depression in a trial published this month, and the result is worth knowing before you buy anything that straps to your head.
FREE 5-MIN ASSESSMENT
How emotionally fit are you? Most men have never measured.
What the trial actually did
The study is called DiSCoVeR, and it ran at university hospitals in Jerusalem, Riga and Munich before landing in JAMA Network Open. According to Medical Xpress’s report on the trial, participants with major depressive disorder came in for a few instructional visits, then did most of their 30 sessions over six weeks at home. Half got real transcranial direct current stimulation (tDCS) plus an action-style game built to train cognitive control. The other half got sham stimulation and a similar-looking game with the training exercises taken out. The trial was registered in advance as NCT04953208 back in 2021, so the plan was on file long before anyone saw a result.
HMP Global’s clinical summary of the paper fills in the specifics. Sessions ran 30 minutes at 2 milliamps. Of 111 people randomized, 109 made the main analysis, and 86 of those (78.9%) finished at least 20 sessions, which is better follow-through than most home protocols get. Then the depression scores. On the MADRS, a standard clinician-rated scale, the active group dropped 7.3 points and the sham group dropped 8.2. The gap wasn’t statistically significant (p = .44), and to the extent it pointed anywhere, it pointed toward the fake. Co-first author Esther Dechantsreiter put it plainly: the findings “do not support routine clinical adoption of the approach in its current form.”
Both groups got better
This is the part a headset company would rather you skimmed. Put yourself in either arm and you’d likely have finished six weeks feeling noticeably better, and you’d very likely have credited the device. The sham group never got the real dose. They improved anyway. Lead researcher Mor Nahum of Hebrew University: “Both groups improved substantially, and that is the finding I keep returning to.”
That does not mean the gains were all placebo, and it’s worth being careful here because the internet won’t be. What the trial shows is that active stimulation added nothing measurable over the comparison condition. It can’t tell you why the comparison condition worked. Medical Xpress notes the researchers couldn’t separate out natural changes in symptoms, the effect of simply being in a study, or other factors. The authors also list possible nonspecific effects of the control game itself as a limitation. And the two arms shared a lot: a set daily task, a study team keeping tabs, and a reason to expect improvement.
One detail I’d read twice. Participants who believed they’d landed in the control group tended to improve less, whichever group they were really in. The researchers are explicit that this doesn’t show belief cures depression. It does show expectation was in the room.
None of this is special to brain stimulation. A 2016 systematic review in Lancet Psychiatry by Furukawa and colleagues pooled 252 placebo-controlled antidepressant trials and found that since 1991, placebo response rates have held steady between 35% and 40%, with response meaning a drop of half or more in the symptom score. Longer trials and multicenter trials ran higher. Those were pills, not gadgets, but the mechanics carry over. In depression, the comparison group moves. A product with no comparison group is showing you that movement and calling it the cause.
Three questions before you pay
Before you spend money on a stimulation headset or a mood app with “clinically inspired” on the box, run it past these.
Is there a sham-controlled trial of this product, or this exact protocol? Not “built on research into tDCS.” A trial where one group got a convincing fake and nobody knew who was who. Look for a registry number and check it on ClinicalTrials.gov, where the planned outcome sits on file before the data come in. Testimonials and before-and-after charts don’t count. The DiSCoVeR sham group would have produced a lovely before-and-after chart.
What did the comparison group get? The marketing never says. If users got a daily ritual and an app pinging them while the comparison group sat on a waitlist with nothing, a win mostly tells you structure and attention help. You knew that already. The comparison to trust is one that looks and feels like the real thing.
What does it cost, measured against what? Don’t price the device against how much better users felt. Price it against the difference over control. Here, with a well-run protocol and three hospital teams behind it, that difference was under a point on a 60-point scale, in the wrong direction. If a headset or a subscription runs into the hundreds of dollars, ask what you’re getting that a routine wouldn’t give you.
Steal the parts both arms had
If both groups improved, the useful question is what both groups had in common. Not the current. Not the specific game. They had a fixed half hour on most days for six weeks, with a start date and an end date. Somebody on a study team knew whether they’d shown up. And they’d signed on to something they had reason to think might help.
The trial doesn’t prove those were the active ingredients either. It only tells you they were present on both sides of a comparison where the expensive part made no difference. They also cost nothing.
Pick a slot at the same time every day and give it a defined run. Six weeks is what the trial used, and a fixed end point makes it easier to start. Fill the slot with something that takes real attention: a hard walk without your phone, or a written check-in with actual questions on it. It won’t replicate tDCS. It’s meant to replicate the scaffolding around it.
Then tell one person what you’re doing and give them permission to ask. A two-word text, “did you?”, is remote supervision without the hardware. Readers who try this tend to report the check-in matters more than they expected, mostly because skipping now means explaining it to someone.
And measure before you start and again at the end, so you’re judging the change by a number instead of by whatever mood you woke up in. The trial used a clinician-rated scale. You can use the free THRESHOLD assessment at /assessment/, about five minutes and 20 questions, as a baseline for the capacities you’re trying to build. Write the date next to the score.
What a home routine doesn’t come with is the safety net DiSCoVeR had. Its participants were screened before enrolling and had a clinical team who could act if things got worse, and two people in the active arm were hospitalized during the study for suicidal thoughts or worsening depression (investigators judged both unlikely to be related to the treatment). If you’re dealing with major depression, the routine goes alongside care, not in place of it. If the low stretch turns into thoughts of not being here, call or text 988.
Produced with AI under BRICK30’s editorial standards and reviewed for accuracy. Informational, not medical advice. If you’re in crisis, call or text 988 (US).